Noubar Afeyan (#2204)
What keeps you from innovating is being comfortable. If you're an immigrant, then you're used to being out of your comfort zone.
- $ 2 B
- Biotech
- United States
- M
- 63 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Noubar Afeyan is the founder and CEO of Cambridge, Mass. life sciences innovation firm Flagship Pioneering. He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19 vaccine which was authorized by the U.S. FDA in December 2020. Afeyan has helped start more than 70 public and private healthcare and life sciences companies over the course of his career. Born in Beirut, Lebanon, in 1962 to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975. Beyond his stake in Moderna, he also owns shares in several publicly traded biotech companies in the U.S.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Noubar Afeyan’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Noubar Afeyan’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.9B
(May 4, 2026)
© Iconic Billionaires